Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd (OXYGENTAPHLTD): company summary
Oxygenta Pharmaceutical Ltd (OXYGENTAPHLTD) is a micro-cap Healthcare company valued at ₹215 crore operating in Pharmaceuticals on the NSE and BSE.
Oxygenta Pharmaceutical Ltd (OXYGENTAPHLTD) is a micro-cap Healthcare company valued at ₹215 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 53.9% a year over three years. Return on equity is 41.2%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -4.85 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5), but held back by quality (2.2). Growth looks strong at 7.5, but that is offset by quality at 2.2. We are calling it Mixed rather than resolving the conflict for you. Scored on 3 of 5 measures.
DocStoX score
Low confidenceScored on 3 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Strong returns on equity (41%)
- Low leverage — D/E 0.00
- Revenue compounding 17% a year
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Oxygenta Pharmaceutical Ltd’s valuation
Free deep-dive tools · no sign-up
Oxygenta Pharmaceutical Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Oxygenta Pharmaceutical Ltd with peers
Related tools & concepts
Value Oxygenta Pharmaceutical Ltd with the ratios and calculators DocStoX uses in its analysis.

